Skip to main content

Table 1 Baseline characteristics

From: Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients

Groups

ACEIs

ARBs

Healthy

test value

P-value

Parameters

Demographics

Age

Mean ± SD

53.5 ± 9.6

54.5 ± 12.2

53.18 ± 8.15

0.106b

0.899

BMI

28.4 ± 5.2

27.9 ± 4

28.8 ± 5.8

0.184b

0.832

Sex M

N (%)

35 (87.5%)

13 (65%)

9 (22.5%)

35.129a

 < 0.001

Sex F

5 (12.5%)

7 (35%)

31 (77.5%)

Comorbidities

DM

No

26 (65%)

13 (65%)

 

0a

1

Yes

14 (35%)

7 (35%)

MI

No

18 (45%)

20 (100%)

17.368a

 < 0.001

Yes

22 (55%)

0 (0%)

HTN

No

21 (52.5%)

11 (55%)

0.033a

0.855

Yes

19 (47.5%)

9 (45%)

EF

Normal

20 (50%)

7 (35%)

4.108a

0.128

Medium

12 (30%)

4 (20%)

Reduced

8 (20%)

9 (45%)

Drugs

beta blockers

No

24 (60%)

15 (75%)

 

1.319a

0.251

Yes

16 (40%)

5 (25%)

Diuretics

No

35 (87.5%)

19 (95%)

 

0.653**

Yes

5 (12.5%)

1 (5%)

calcium blockers

No

38 (95%)

19 (95%)

small number

Yes

2 (5%)

1 (5%)

 
  1. ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, BMI body mass index, DM diabetes mellitus, HTN hypertension, EF Ejection fraction
  2. achi square test,**Fischer exact, bANOVA test